Physician profile
John Gray
NPI 1205885910
$886.63
in general payments reported to CMS, 2019-2025
12 companies · $55.56 in 2025
The $55.56 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $75.42 · 2021: $176 · 2022: $175 · 2023: $143 · 2024: $96.65 · 2025: $55.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $294.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirtex Medical INC | $404.97 | 2019-2023 | Sir-Spheres Microspheres |
| Balt USA, LLC | $107.47 | 2021-2025 | Prestige Coil System |
| Stryker Corporation | $85.09 | 2022 | |
| Medtronic, INC. | $67.91 | 2024 | Hawkone |
| Boston Scientific Corporation | $66.01 | 2020-2021 | |
| Terumo Medical Corporation | $30.70 | 2022 | |
| Ge Healthcare | $29.98 | 2025 | |
| Tactile Systems Technology INC | $28.74 | 2024 | Entre Plus, Flexitouch Plus |
| Medtronic Vascular, INC. | $23.75 | 2020 | |
| Tetraphase Pharmaceuticals, INC. | $17.67 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.72 | 2019 | |
| Covidien LP | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.